Advertisement
U.S. markets closed

OptimizeRx Corporation (OPRX)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
15.17-0.03 (-0.20%)
At close: 04:00PM EST
15.17 0.00 (0.00%)
After hours: 08:00PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Momentum

Momentum

Previous Close15.20
Open15.26
Bid12.38 x 800
Ask24.33 x 800
Day's Range14.94 - 15.29
52 Week Range6.92 - 18.65
Volume70,245
Avg. Volume145,588
Market Cap275.373M
Beta (5Y Monthly)1.02
PE Ratio (TTM)N/A
EPS (TTM)-0.81
Earnings DateMay 08, 2024 - May 13, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est16.40
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for OPRX

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • OptimizeRx Corporation
    OPRX: Lowering target price to $10.00OPTIMIZERX CORP has an Investment Rating of SELL; a target price of $10.000000; an Industry Subrating of Medium; a Management Subrating of Low; a Safety Subrating of Low; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of High.
    Rating
    Fair Value
    Economic Moat
    11 months agoArgus Research
View more
  • GlobeNewswire

    OptimizeRx to Participate in Upcoming Investor Conferences

    WALTHAM, Mass., Feb. 21, 2024 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), the leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients, today announced that management will participate in the following upcoming investor conferences: Barclays 26th Annual Global Healthcare Conference, Miami Beach, March 13th, 202436th Annual ROTH Conference, Dana Point, March 17th – March 19th, 2024 Ma

  • Zacks

    Bruker (BRKR) Q4 Earnings and Revenues Top Estimates

    Bruker (BRKR) delivered earnings and revenue surprises of 7.69% and 2.87%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?

  • GlobeNewswire

    OptimizeRx Announces Strategic Board Changes to Support Growth and Evolving Landscape

    WALTHAM, Mass., Jan. 25, 2024 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients, is pleased to announce changes to its Board of Directors reflecting a strategic move to further align with the company’s growth plans. After nearly a decade of service, Gus Halas is retiring from his position as Chairperson of the Board. During his ten